Page last updated: 2024-09-05

miconidin and 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid

miconidin has been researched along with 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid in 1 studies

Compound Research Comparison

Studies
(miconidin)
Trials
(miconidin)
Recent Studies (post-2010)
(miconidin)
Studies
(6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid)
Trials
(6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid)
Recent Studies (post-2010) (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid)
6021,54116580

Protein Interaction Comparison

ProteinTaxonomymiconidin (IC50)6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (IC50)
Prostaglandin G/H synthase 1Homo sapiens (human)0.13
Prostaglandin G/H synthase 2Homo sapiens (human)0.15

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dvorakova, M; Jarosova, V; Landa, P; Sisa, M; Temml, V; Vanek, T1

Other Studies

1 other study(ies) available for miconidin and 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid

ArticleYear
Synthesis, inhibitory activity and in silico docking of dual COX/5-LOX inhibitors with quinone and resorcinol core.
    European journal of medicinal chemistry, 2020, Oct-15, Volume: 204

    Topics: Benzoquinones; Catalytic Domain; Computer Simulation; Cyclooxygenase Inhibitors; Lipoxygenase Inhibitors; Molecular Docking Simulation; Oxidation-Reduction; Resorcinols; Spectrum Analysis; Structure-Activity Relationship

2020